Skip to main content

Main menu

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
  • SPECIAL ISSUES
    • Artificial Intelligence in Primary Care: call for articles
    • Social Care Integration with Primary Care: call for articles
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
    • Top 10 Research Articles of the Year
  • BJGP CONFERENCE →
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Alerts

Search

  • Advanced search
Intended for Healthcare Professionals
BJGP Open
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow BJGP Open on Instagram
  • Visit bjgp open on Bluesky
  • Blog
Intended for Healthcare Professionals
BJGP Open

Advanced Search

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
  • SPECIAL ISSUES
    • Artificial Intelligence in Primary Care: call for articles
    • Social Care Integration with Primary Care: call for articles
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
    • Top 10 Research Articles of the Year
  • BJGP CONFERENCE →
Research

Effectiveness of smoking cessation interventions in pregnant women attending primary care: a scoping review

Niamh Connolly, Dervla Kelly, Patrick O'Donnell and Sarah Hyde
BJGP Open 2024; 8 (3): BJGPO.2023.0185. DOI: https://doi.org/10.3399/BJGPO.2023.0185
Niamh Connolly
1 School of Medicine, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niamh Connolly
  • For correspondence: niamhcy@gmail.com
Dervla Kelly
1 School of Medicine, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dervla Kelly
Patrick O'Donnell
1 School of Medicine, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick O'Donnell
Sarah Hyde
1 School of Medicine, University of Limerick, Limerick, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah Hyde
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading

Abstract

Background Smoking during pregnancy has many adverse effects for infant and mother. Despite this, many pregnant women continue smoking. Primary care is a suitable area to provide smoking cessation interventions.

Aim To investigate available literature regarding effectiveness of smoking cessation interventions for pregnant women in primary care, the factors contributing to this effectiveness, and to provide suggestions for future research.

Design & setting Systematic scoping literature review.

Method The methodology followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews. Five electronic databases were searched. Inclusion criteria included original research studies and studies published in English. Data were extracted using a modified Joanna Briggs Institute (JBI) data-charting tool.

Results The initial search yielded 878 articles. Following article screening, 12 studies were included. Five studies found a statistically significant increase in smoking cessation rates or reduction in tobacco consumed in the intervention group. The remaining studies showed no significant difference between the groups. However, 10 studies showed the control group received usual antenatal care involving smoking cessation promotion. An increase in smoking cessation rates was seen in intervention and control groups, demonstrating the effectiveness of these interventions. Interventions included education, counselling, self-help, and financial incentives. They were delivered by GPs, midwives, counsellors, and pregnancy advisers.

Conclusion Primary care is suitable to offer smoking cessation interventions to pregnant women, as it is often the first point of care and more easily accessible than secondary care. Future research is needed to determine the most effective types of interventions.

  • smoking intervention
  • smoking
  • pregnancy
  • primary health care

How this fits in

The World Health Organization (WHO) recommends that all pregnant women who use tobacco should be offered a brief intervention, despite the quality of evidence for this being low. This review shows that primary care is a suitable location to provide this service. However, further research is needed to determine if reduction in tobacco consumption is owing to interventions, or whether pregnancy itself and/or increased contact with healthcare professionals are the main motivators for behavioural change. There is scope for future research to identify the most effective smoking cessation interventions and how they can be delivered.

Introduction

Tobacco use during pregnancy has many negative outcomes, including increased risk of miscarriage, stillbirth, and premature labour.1 The Centers for Disease Control and Prevention (CDC) report that 20% of babies born to mothers who smoke are of low birth weight and more likely to die from sudden infant death syndrome.2 The infant mortality rate in those born to mothers who smoke is estimated to be 40% higher than infants not exposed to tobacco.3 Smoking in pregnancy is associated with increased obstetric risk4–6 and linked with adverse effects to the baby later in life, including increased risk of asthma,7 obesity,8 and reduced academic achievement.9

Unfortunately, many pregnant women continue to smoke. A 2018 meta-analysis reported that 8% of women in Europe smoked during pregnancy.10 In the US, 7.2% of women who gave birth in 2016 smoked during pregnancy.11 This behaviour causes financial burdens on healthcare systems. A study in England showed that children of women who smoked during pregnancy have higher healthcare costs during their first 5 years of life.12 The quantity of cigarettes influences the financial impact, with children of mothers smoking >20 cigarettes daily having the highest cost difference.13 In 1993, tobacco use during pregnancy resulted in healthcare costs of $135–$167 million in the US.14

The World Health Organization (WHO) states that primary care is an effective healthcare setting for providing smoking cessation support to all patients.15 It is recommended that pregnant smokers should be offered advice, behavioural support, and pharmacotherapy.16 The American College of Obstetricians and Gynecologists (ACOG) suggests that primary care professionals should provide interventions during pregnancy.17 However, it has been reported that community healthcare providers miss opportunities for interventions by not discussing tobacco use consistently with patients who are pregnant.18

Several smoking cessation interventions during pregnancy have been studied. For motivational interviewing, results are mixed with some studies showing increased cessation rates and others demonstrating no improvement.19,20 Nicotine replacement therapy (NRT) effects in pregnancy are also mixed.21–23 A Cochrane review stated further research is needed on the efficacy and safety of pharmacotherapy for smoking cessation in pregnancy.24

Opinions of primary care professionals and patients regarding provision of smoking cessation services have been investigated. Obstacles described include lack of resources, time, training and clarity regarding policies and guidelines.25–28 One review identified that although primary care professionals accept their role in promoting smoking cessation, they disagree on the level of involvement they should have.27 Patients believe that smoking cessation should be discussed routinely during general practice consultations.29

Evidence regarding smoking cessation services for pregnant women in primary care is lacking. The aim of this review is to assess the effectiveness of smoking cessation interventions in pregnant women in primary care. A scoping review was done to map existing literature and identify knowledge gaps. To our knowledge, this is the first scoping review to do so. Mapping existing literature will contribute to developing effective smoking cessation strategies for pregnant women. This can allow a more specific research question to be answered by a systematic or meta-analysis study.

Method

A systematic scoping review was completed, adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews.30 The methodology was based on Arksey and O’Malley’s framework.31

Identifying the research question

This scoping review aimed to answer the following question: what is the effectiveness of smoking cessation interventions for pregnant women in primary care and what factors contribute to this effectiveness? Based on this question, inclusion and exclusion criteria were determined.

Identifying relevant studies

The following five electronic databases were searched: CINAHL, MEDLINE, Embase, Scopus, and Cochrane, using the key terms: (pregnancy OR pregnant OR prenatal OR antenatal OR perinatal OR maternal) AND (smoking OR tobacco OR cigarette OR nicotine) AND (general practice OR GP OR primary care OR primary healthcare OR family practice OR family medicine) AND (interventions OR strategies OR programme).

The inclusion criteria were as follows: studies involving smoking cessation interventions in pregnant women; studies undertaken in primary care settings (primary care, community clinics, or general practices explicitly stated); original research studies; and studies published in English.

The exclusion criteria were as follows: studies involving non-pregnant women; studies undertaken in secondary or tertiary care; non-original research; and studies not published in English.

Study selection

The article titles yielded were screened manually by two authors and those determined as not eligible were eliminated. The abstracts of the remaining articles were screened and if considered relevant, the full article was reviewed.

Charting the data

A data-charting spreadsheet adapted from the Joanna Briggs Institute (JBI) was developed. The following data were extracted: author(s); year of publication; country of origin; study setting; study design; study population and sample size; intervention details; control group; study outcomes; and key findings. Articles were analysed, producing a descriptive summary aligning with the aims of the review.

Collating, summarising, and reporting the results

A narrative analysis of the heterogenous studies was completed and reviewed by three authors. The results were mapped and presented in accordance with the objectives. Gaps in knowledge were identified. Quality assessment of the evidence was not a primary objective.31 Following reporting of results, stakeholder input was sought. A primary care physician with expertise in addiction reviewed the results.

Results

Mapping the results

The database search yielded n = 878 articles. Following a duplicate screen, n = 208 articles were removed. Article titles were screened according to PRISMA guidelines and those deemed not appropriate (n = 442) were eliminated. The remaining n = 228 abstracts were reviewed according to the inclusion criteria. This resulted in n = 189 abstracts being eliminated and n = 39 full articles being reviewed. A further n = 27 articles were eliminated owing to the studies not fulfilling inclusion criteria. The final number of articles was n = 12 (Figure 1). The studies are summarised in Supplementary Table S1.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1. PRISMA flowchart

Study characteristics

Study year ranged from 1989–2020, reflecting that smoking cessation in pregnancy is a long-standing issue in primary care. The range of countries comprised: the Netherlands (n = 1), Norway (n = 3), the UK (n = 2), the US (n = 3), Australia (n = 1), New Zealand (n = 1), and South Africa (n = 1). Methods used included randomised controlled trials (n = 5), non-randomised controlled trials (n = 2), cluster randomised trials (n = 2), prospective observational study (n = 1), quasi-experimental study (n = 1), and mixed-method study (n = 1). Study populations ranged from n = 109 to n = 7845. The stage of pregnancy at which participants were recruited varied: booking visit (n = 3), <20 weeks gestation (n = 1), <25 weeks gestation (n = 1), <28 weeks gestation (n = 3), 12–30 weeks gestation (n = 1), and unspecified gestational date for recruitment (n = 3).

Study interventions

All interventions incorporated behavioural technique interventions. The exact intervention methods differed between studies but largely consisted of motivational interviewing, counselling, education, self-help, and financial incentives. The 5As intervention was used in two studies and one study focused on the transtheoretical (stages of change) model.32–36 NRT was offered in one study after two failed cessation attempts.32 The primary care facilities offering the intervention differed with n = 4 midwifery clinics, n = 3 general practices, n = 1 midwifery clinics and general practices, n = 2 primary care antenatal clinics, and n = 2 primary care antenatal clinics and general practices.

Study outcomes

Five studies indicated that the intervention significantly reduced tobacco use in pregnancy.37–41 These interventions included the 5As intervention, psycho-educational methods, counselling sessions, motivational interviewing, and structured smoking cessation education. In two studies, where the intervention was worthwhile, participants were financially rewarded for participating in the study.37,39

Seven studies demonstrated the intervention did not cause a statistically significant increase in smoking cessation rates or reduction in the number of cigarettes smoked.32–34,42–45 Messimer et al reported that 28% of the intervention group quit smoking by 32–36 weeks gestation; however, this did not reach statistical significance.45 Lawrence et al reported that in two different intervention groups, 2.6% and 3.1% had sustained abstinence at 30 weeks gestation.34 Most of these seven studies reported positive results in intervention and control groups, indicating no significant effect from the intervention. In most studies, women in the control group received usual care from their primary care provider. Most studies described usual care as providing some smoking cessation advice, but not as intensive as the intervention.

Stakeholder consultation was not reported in any of the studies, demonstrating a lack of stakeholder involvement.

Discussion

Summary

This scoping review identified twelve studies that investigated the impact of smoking cessation interventions on pregnant women in primary care. The interventions may have increased smoking cessation rates in pregnant women; however, it cannot be determined if the increase was attributable to the interventions, or if pregnancy itself and increased contact with healthcare professionals were the reasons for decreased tobacco consumption.

Strengths and limitations

Regarding strengths, this review strictly followed the methodology framework of Arksey and O’Malley.31 Following collation of results, stakeholder input was sought. A primary care physician with expertise in addiction reviewed and corroborated the results without identifying further gaps.

Regarding limitations, this study was limited to the population of currently pregnant women, and did not assess pre-pregnancy or post-partum periods. The heterogeneity of the study methods means that some studies contained information not specific to the research question. However, Arksey and O’Malley state that comprehensiveness is a critical component of scoping reviews.31 Studies not published in English were not reviewed, possibly introducing bias. It is also not possible to exclude selection and reporting bias in this study. Finally, this is a scoping review and therefore the quality of the studies included has not been assessed.

Comparison with existing literature

Regarding effectiveness of smoking cessation interventions in primary care, most of the studies did not report a statistically significant difference in smoking cessation between intervention and control groups. However, it is important to note that even in the control group, some level of smoking cessation advice was offered. In all studies, there was some increase in smoking cessation rates or reduction in amount of tobacco smoked in both groups (if a control group was used). It is possible that interventions of any kind within primary care may positively impact smoking cessation or reduction rates. Pregnancy itself may be a strong motivator to quit smoking. One study reported that pregnancy was the indication most pregnant women stopped smoking, and the motivation could not be attributed to the intervention.45 Another study that found motivational interviewing and a financial incentive increased smoking cessation rates reported that women who enrol in cessation programmes may have higher motivational desire to quit smoking than those who do not enrol and therefore, it cannot be determined whether the interventions are completely responsible for increased cessation.37 Oude Wesselink et al showed the control group had the same cessation rate as the intervention group.43 From these results, it is difficult to attribute the cause of smoking cessation to a single factor.

Limitations were noted in some studies. Oude Wesselink et al found that not all recommended counselling steps were delivered.43 The cessation rate in women who received stage 1 of this counselling technique was 10%. This increased to 16% when all steps were completed. Regarding cost-effectiveness, Robling et al stated that adding Family Nurse Partnership (FNP) to usual care resulted in substantial additional cost, which was not substantiated by the intervention effects.42 In addition to the study by Robling et al, which investigated teenage mothers, only three other studies examined demographic and socioeconomic factors. One study involving the Aboriginal community determined that there was no additional benefit from a high-intensity quit-smoking intervention.32 Joseph et al investigated smoking among high-risk, pregnant African–American and Latina women and found that the intervention group more frequently resolved some or all of their risks.39 The low number of studies investigating demographic and socioeconomic factors related to this topic suggests that future research would be valuable.

Regarding different smoking cessation interventions, the interventions used in the five positive studies were as follows: motivational interviewing and a financial incentive; 5As intervention and psycho-educational methods; clinic-based individually tailored counselling sessions; structured smoking cessation education; and an information flip-over and booklet provided with extra GP consultations.37–41 The 5As intervention method used in another study and an intervention adapted from the clinical practice guideline Treating Tobacco Use and Dependence also resulted in significant reduction in smoking rates but was not deemed significant compared with the control group.33,44

Other interventions that were not clinically significant included home-visiting programmes, counselling, and a transtheoretical model based self-help manual. NRT was offered in one study but did not show a significant benefit for smoking cessation.32 It is not exactly clear why some of these interventions were effective while others were not but lack of training of healthcare professionals, poor delivery of the intervention, and pregnant women not participating as expected were reported as factors that limited the efficacy of interventions.

Regarding primary care settings and providers, McLeod et al acknowledged that most smoking cessation interventions for pregnant women have been studied in secondary or tertiary settings. This study found that in New Zealand, primary care midwives are increasingly expected to deliver health promotion messages to pregnant patients and often attend patients in their homes rather than clinics.40 Smoking cessation interventions may be more effective in this setting, although this has not been investigated. In a different New Zealand study, while midwives appear excellently placed to deliver brief interventions for smoking, only half of midwives reported offering interventions to pregnant smokers.46

Pregnant women encounter more difficulty in accessing smoking cessation services compared with non-pregnant women owing to potential stigma and insufficient programmes.46 One study illustrated the feasibility of non-medical professionals delivering primary care interventions and determined further research is required for identifying optimal methods to provide this service.39 Another study suggested that GPs should be trained further in this area.41 A range of healthcare professionals offered interventions in the five positive studies, including GPs, midwives, counsellors, and specially trained pregnancy advisers.37–41 There is scope for investigating interventions not provided by healthcare professionals such as those instigated by family and friends or through multimedia.

Implications for research and practice

This scoping review allowed available literature to be mapped and summarised, and gaps to be identified. To understand factors that may strengthen or weaken motivation to cease smoking, further research is indicated. Pregnant women should be consulted for a collaborative approach and perspectives of primary care workers should be explored. Resource-directed aspects, such as cost-benefit analysis, would be beneficial. Investigating the relationship between factors, such as socioeconomic status and smoking cessation in pregnancy, would also be useful. The purpose of doing more research into this topic is to find appropriate interventions that can reduce smoking in pregnancy and therefore reduce harm to both mother and baby. Primary care is one of the most easily accessible healthcare areas as it is community based and it is often the first point of care for pregnant women. Therefore, it is an ideal area to provide smoking cessation interventions to this population.

Notes

Funding

No funding to declare.

Ethical Approval

This study was a scoping review and did not involve human or animal participants. Therefore, this study did not require ethical approval.

Provenance

Freely submitted; externally peer reviewed.

Competing interests

The authors declare that no competing interests exist.

  • Received September 19, 2023.
  • Revision received February 5, 2024.
  • Accepted February 20, 2024.
  • Copyright © 2024, The Authors

This article is Open Access: CC BY license (https://creativecommons.org/licenses/by/4.0/)

References

  1. 1.↵
    1. World Health Organization (WHO)
    (2013) WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy. accessed. https://www.who.int/publications/i/item/9789241506076. 15 May 2024.
  2. 2.↵
    1. Centers for Disease Control and Prevention
    (2004) 2004 Surgeon General’s Report: the health consequences of smoking. accessed. https://archive.cdc.gov/#/details?url=https://www.cdc.gov/tobacco/sgr/2004/highlights.html. 15 May 2024.
  3. 3.↵
    1. Salihu HM,
    2. Aliyu MH,
    3. Pierre-Louis BJ,
    4. Alexander GR
    (2003) Levels of excess infant deaths attributable to maternal smoking during pregnancy in the United States. Matern Child Health J 7 (4):219–227, doi:10.1023/a:1027319517405, pmid:14682499.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Shobeiri F,
    2. Jenabi E
    (2017) Smoking and placenta previa: a meta-analysis. J Matern Fetal Neonatal Med 30 (24):2985–2990, doi:10.1080/14767058.2016.1271405, pmid:27936997.
    OpenUrlCrossRefPubMed
  5. 5.
    1. Shobeiri F,
    2. Masoumi SZ,
    3. Jenabi E
    (2017) The association between maternal smoking and placenta abruption: a meta-analysis. J Matern Fetal Neonatal Med 30 (16):1963–1967, doi:10.1080/14767058.2016.1235694, pmid:27623712.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Castles A,
    2. Adams EK,
    3. Melvin CL,
    4. et al.
    (1999) Effects of smoking during pregnancy. Am J Prev Med 16 (3):208–215, doi:10.1016/S0749-3797(98)00089-0.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Hollams EM,
    2. de Klerk NH,
    3. Holt PG,
    4. Sly PD
    (2014) Persistent effects of maternal smoking during pregnancy on lung function and asthma in adolescents. Am J Respir Crit Care Med 189 (4):401–407, doi:10.1164/rccm.201302-0323OC, pmid:24251622.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Ino T
    (2010) Maternal smoking during pregnancy and offspring obesity: meta-analysis. Pediatr Int 52 (1):94–99, doi:10.1111/j.1442-200X.2009.02883.x, pmid:19400912.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Clifford A,
    2. Lang L,
    3. Chen R
    (2012) Effects of maternal cigarette smoking during pregnancy on cognitive parameters of children and young adults: a literature review. Neurotoxicol Teratol 34 (6):560–570, doi:10.1016/j.ntt.2012.09.004, pmid:23022448. S0892-0362(12)00163-8.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Lange S,
    2. Probst C,
    3. Rehm J,
    4. Popova S
    (2018) National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Glob Health 6 (7):e769–e776, doi:10.1016/S2214-109X(18)30223-7, pmid:29859815. S2214-109X(18)30223-7.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Drake P,
    2. Driscoll A,
    3. Mathews TJ
    (2018) Cigarette smoking during pregnancy: United States, 2016. accessed. https://www.cdc.gov/nchs/data/databriefs/db305.pdf. 15 May 2024.
  12. 12.↵
    1. Vaz LR,
    2. Jones MJ,
    3. Szatkowski L,
    4. et al.
    (2018) Estimating the health-care costs of children born to pregnant smokers in England: cohort study using primary and secondary health-care data. Addiction 113 (7):1305–1316, doi:10.1111/add.14183, pmid:29397000.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Petrou S,
    2. Hockley C,
    3. Mehta Z,
    4. Goldacre M
    (2005) The association between smoking during pregnancy and hospital inpatient costs in childhood. Soc Sci Med 60 (5):1071–1085, doi:10.1016/j.socscimed.2004.06.035, pmid:15589675.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Adams EK,
    2. Melvin CL
    (1998) Costs of maternal conditions attributable to smoking during pregnancy. Am J Prev Med 15 (3):212–219, doi:10.1016/s0749-3797(98)00049-x, pmid:9791639. https://doi.org/10.1016/s0749-3797(98)00049-x.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. WHO
    (2014) Toolkit for delivering the 5As and 5Rs brief tobacco interventions in primary care. accessed. http://apps.who.int/iris/bitstream/handle/10665/112835/9789241506953_eng.pdf;sequence=1. 15 May 2024.
  16. 16.↵
    1. Verbiest M,
    2. Brakema E,
    3. van der Kleij R,
    4. et al.
    (2017) National guidelines for smoking cessation in primary care: a literature review and evidence analysis. NPJ Prim Care Respir Med 27 (1), doi:10.1038/s41533-016-0004-8, pmid:28108747. 2.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. American College of Obstetricians and Gynecologists Committee on Health Care for Undeserved Women
    (2006) ACOG Committee opinion No.343: Psychosocial risk factors: perinatal screening and intervention. Obstet Gynecol 108 (2):469, doi:10.1097/00006250-200608000-00046, pmid:16880322.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Zapka JG,
    2. Pbert L,
    3. Stoddard AM,
    4. et al.
    (2000) Smoking cessation counseling with pregnant and postpartum women: a survey of community health center providers. Am J Public Health 90 (1):78–84, doi:10.2105/ajph.90.1.78, pmid:10630141.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Karatay G,
    2. Kublay G,
    3. Emiroğlu ON
    (2010) Effect of motivational interviewing on smoking cessation in pregnant women. J Adv Nurs 66 (6):1328–1337, doi:10.1111/j.1365-2648.2010.05267.x, pmid:20384640.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Tappin DM,
    2. Lumsden MA,
    3. Gilmour WH,
    4. et al.
    (2005) Randomised controlled trial of home based motivational interviewing by midwives to help pregnant Smokers quit or cut down. BMJ 331 (7513):373–377, doi:10.1136/bmj.331.7513.373, pmid:16096304.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Brose LS,
    2. McEwen A,
    3. West R
    (2013) Association between nicotine replacement therapy use in pregnancy and smoking cessation. Drug Alcohol Depend 132 (3):660–664, doi:10.1016/j.drugalcdep.2013.04.017, pmid:23680076. S0376-8716(13)00146-4.
    OpenUrlCrossRefPubMed
  22. 22.
    1. Blanc J,
    2. Tosello B,
    3. Ekblad MO,
    4. et al.
    (2021) Nicotine replacement therapy during pregnancy and child health outcomes: a systematic review. Int J Environ Res Public Health 18 (8), doi:10.3390/ijerph18084004, pmid:33920348. 4004.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Bar-Zeev Y,
    2. Lim LL,
    3. Bonevski B,
    4. et al.
    (2018) Nicotine replacement therapy for smoking cessation during pregnancy. Med J Aust 208 (1):46–51, doi:10.5694/mja17.00446, pmid:29320660.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Claire R,
    2. Chamberlain C,
    3. Davey M-A,
    4. et al.
    (2020) Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 3 (3), doi:10.1002/14651858.CD010078.pub3, pmid:32129504. CD010078.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Kumar R,
    2. Stevenson L,
    3. Jobling J,
    4. et al.
    (2021) Correction to: Health providers’ and pregnant women’s perspectives about smoking cessation support: a COM-B analysis of a global systematic review of qualitative studies. BMC Pregnancy Childbirth 21 (1), doi:10.1186/s12884-021-04094-9, pmid:34496776. 613.
    OpenUrlCrossRefPubMed
  26. 26.
    1. Naughton F,
    2. Hopewell S,
    3. Sinclair L,
    4. et al.
    (2018) Barriers and facilitators to smoking cessation in pregnancy and in the post‐partum period: the health care professionals’ perspective. Br J Health Psychol 23 (3):741–757, doi:10.1111/bjhp.12314, pmid:29766615.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Manolios E,
    2. Sibeoni J,
    3. Teixeira M,
    4. et al.
    (2021) When primary care providers and Smokers meet: a systematic review and metasynthesis. NPJ Prim Care Respir Med 31 (1), doi:10.1038/s41533-021-00245-9, pmid:34075057. 31.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Bell K,
    2. Bowers M,
    3. McCullough L,
    4. Bell J
    (2012) Physician advice for smoking cessation in primary care: time for a paradigm shift. Critical Public Health 22 (1):9–24, doi:10.1080/09581596.2011.572155.
    OpenUrlCrossRef
  29. 29.↵
    1. Guassora AD,
    2. Baarts C
    (2010) Smoking cessation advice in consultations with health problems not related to smoking? Relevance criteria in Danish general practice consultations. Scand J Prim Health Care 28 (4):221–228, doi:10.3109/02813432.2010.506805, pmid:20704522.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Tricco AC,
    2. Lillie E,
    3. Zarin W,
    4. et al.
    (2018) PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169 (7):467–473, doi:10.7326/M18-0850, pmid:30178033.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Arksey H,
    2. O’Malley L
    (2005) Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8 (1):19–32, doi:10.1080/1364557032000119616.
    OpenUrlCrossRef
  32. 32.↵
    1. Eades SJ,
    2. Sanson-Fisher RW,
    3. Wenitong M,
    4. et al.
    (2012) An intensive smoking intervention for pregnant Aboriginal and Torres Strait Islander women: a randomised controlled trial. Med J Aust 197 (1):42–46, doi:10.5694/mja11.10858, pmid:22762231.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Storrø O,
    2. Oien T,
    3. Dotterud CK,
    4. et al.
    (2010) A primary health-care intervention on pre- and postnatal risk factor behavior to prevent childhood allergy. The Prevention of Allergy among Children in Trondheim (PACT) study. BMC Public Health 10 (1), doi:10.1186/1471-2458-10-443, pmid:20667103. 443.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Lawrence T,
    2. Aveyard P,
    3. Evans O,
    4. Cheng KK
    (2003) A cluster randomised controlled trial of smoking cessation in pregnant women comparing interventions based on the transtheoretical (stages of change) model to standard care. Tob Control 12 (2):168–177, doi:10.1136/tc.12.2.168, pmid:12773727.
    OpenUrlAbstract/FREE Full Text
  35. 35.
    1. Agency for Healthcare Research and Quality
    (2008) The “5 A’s” model for treating tobacco use and dependence. accessed. https://www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-overview/slide43.html. 15 May 2024.
  36. 36.↵
    1. Boston University School of Public Health
    (2022) The transtheoretical model (stages of change). accessed. https://sphweb.bumc.bu.edu/otlt/mph-modules/sb/behavioralchangetheories/behavioralchangetheories6.html. 15 May 2024.
  37. 37.↵
    1. Polinski KJ,
    2. Wolfe R,
    3. Peterson A,
    4. et al.
    (2020) Impact of an incentive‐based prenatal smoking cessation program for low‐income women in Colorado. Public Health Nurs 37 (1):39–49, doi:10.1111/phn.12682, pmid:31692104.
    OpenUrlCrossRefPubMed
  38. 38.
    1. Sorsdahl K,
    2. Petersen Williams P,
    3. Everett-Murphy K,
    4. et al.
    (2015) Feasibility and preliminary responses to a screening and brief intervention program for maternal mental disorders within the context of primary care. Community Ment Health J 51 (8):962–969, doi:10.1007/s10597-015-9853-9, pmid:25744699.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Joseph JG,
    2. El-Mohandes AAE,
    3. Kiely M,
    4. et al.
    (2009) Reducing psychosocial and behavioral pregnancy risk factors: results of a randomized clinical trial among high-risk pregnant African American women. Am J Public Health 99 (6):1053–1061, doi:10.2105/AJPH.2007.131425, pmid:19372532.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. McLeod D,
    2. Pullon S,
    3. Benn C,
    4. et al.
    (2004) Can support and education for smoking cessation and reduction be provided effectively by midwives within primary maternity care? Midwifery 20 (1):37–50, doi:10.1016/S0266-6138(03)00051-2, pmid:15020026.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Haug K,
    2. Fugelli P,
    3. Aarø LE,
    4. Foss OP
    (1994) Is smoking intervention in general practice more successful among pregnant than non-pregnant women? Fam Pract 11 (2):111–116, doi:10.1093/fampra/11.2.111, pmid:7958571.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Robling M,
    2. Bekkers M-J,
    3. Bell K,
    4. et al.
    (2016) Effectiveness of a nurse-led intensive home-visitation programme for first-time teenage mothers (Building Blocks): a pragmatic randomised controlled trial. Lancet 387 (10014):146–155, doi:10.1016/S0140-6736(15)00392-X, pmid:26474809. S0140-6736(15)00392-X.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Oude Wesselink SF,
    2. Lingsma HF,
    3. Robben PBM,
    4. Mackenbach JP
    (2015) Provision and effect of quit-smoking counselling by primary care midwives. Midwifery 31 (10):986–992, doi:10.1016/j.midw.2015.05.010, pmid:26119832. S0266-6138(15)00187-4.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Øien T,
    2. Storrø O,
    3. Jenssen JA,
    4. Johnsen R
    (2008) The impact of a minimal smoking cessation intervention for pregnant women and their partners on perinatal smoking behaviour in primary health care: a real-life controlled study. BMC Public Health 8 (1), doi:10.1186/1471-2458-8-325, pmid:18808705. 325.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Messimer SR,
    2. Hickner JM,
    3. Henry RC
    (1989) A comparison of two antismoking interventions among pregnant women in eleven private primary care practices. J Fam Pract 28 (3):283–288, pmid:2926343.
    OpenUrlPubMed
  46. 46.↵
    1. McLeod D,
    2. Benn C,
    3. Pullon S,
    4. et al.
    (2003) The midwife’s role in facilitating smoking behaviour change during pregnancy. Midwifery 19 (4):285–297, doi:10.1016/s0266-6138(03)00038-x, pmid:14623508.
    OpenUrlCrossRefPubMed
Back to top
Previous ArticleNext Article

In this issue

BJGP Open
Vol. 8, Issue 3
October 2024
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Email Article

Thank you for recommending BJGP Open.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effectiveness of smoking cessation interventions in pregnant women attending primary care: a scoping review
(Your Name) has forwarded a page to you from BJGP Open
(Your Name) thought you would like to see this page from BJGP Open.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effectiveness of smoking cessation interventions in pregnant women attending primary care: a scoping review
Niamh Connolly, Dervla Kelly, Patrick O'Donnell, Sarah Hyde
BJGP Open 2024; 8 (3): BJGPO.2023.0185. DOI: 10.3399/BJGPO.2023.0185

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effectiveness of smoking cessation interventions in pregnant women attending primary care: a scoping review
Niamh Connolly, Dervla Kelly, Patrick O'Donnell, Sarah Hyde
BJGP Open 2024; 8 (3): BJGPO.2023.0185. DOI: 10.3399/BJGPO.2023.0185
del.icio.us logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Mendeley logo Mendeley

Jump to section

  • Top
  • Article
    • Abstract
    • How this fits in
    • Introduction
    • Method
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • Info
  • eLetters
  • PDF

Keywords

  • smoking intervention
  • smoking
  • pregnancy
  • Primary health care

More in this TOC Section

  • Podcasting in primary care: attitudes of Scottish GP specialty trainees and trainers towards podcast-based education in primary care
  • Patient perceptions of relational continuity in England: insights from two cross-sectional surveys
  • COVID-19 and patient-reported experience of general practice in England
Show more Research

Related Articles

Cited By...

Intended for Healthcare Professionals

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Latest articles
  • Authors & reviewers
  • Accessibility statement

RCGP

  • British Journal of General Practice
  • BJGP for RCGP members
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP Open
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP Open: research
  • Writing for BJGP Open: practice & policy
  • BJGP Open editorial process & policies
  • BJGP Open ethical guidelines
  • Peer review for BJGP Open

CUSTOMER SERVICES

  • Advertising
  • Open access licence

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Open Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: bjgpopen@rcgp.org.uk

BJGP Open is an editorially-independent publication of the Royal College of General Practitioners

© 2025 BJGP Open

Online ISSN: 2398-3795